| Autor: |
Xhepa, E, Tada, T, Kufner, S, Ndrepepa, G, Byrne, RA, Kreutzer, J, Ibrahim, T, Tiroch, K, Valgimigli, M (Marco), Tolg, R, Cassese, S, Fusaro, M, Schunkert, H, Laugwitz, KL, Mehilli, J, Kastrati, A |
| Přispěvatelé: |
Cardiology |
| Jazyk: |
angličtina |
| Rok vydání: |
2017 |
| Předmět: |
|
| Zdroj: |
Catheterization and Cardiovascular Interventions, 89(1), 1-10. Wiley-Liss Inc. |
| ISSN: |
1522-1946 |
| DOI: |
10.7892/boris.92846 |
| Popis: |
OBJECTIVES To evaluate the long-term prognostic value of risk scores in the setting of drug-eluting stent (DES) implantation for uLMCA. BACKGROUND Data on the prognostic value of novel risk scores developed to select the most appropriate revascularization strategy in patients undergoing DES implantation for uLMCA disease are relatively limited. METHODS The study represents a patient-level pooled analysis of the ISAR-LEFT-MAIN (607 patients randomized to paclitaxel-eluting or sirolimus-eluting stents) and the ISAR-LEFT-MAIN-2 (650 patients randomized to everolimus-eluting or zotarolimus-eluting stents) randomized trials. The Syntax Score (SxScore) as well the Syntax Score II (SS-II), the EuroSCORE and the Global Risk Classification (GRC) were calculated. The primary outcome was all-cause mortality. RESULTS At a mean follow-up of 3 years there were 160 deaths (12.7%). The death-incidence was significantly higher in the upper tertiles than in the intermediate or lower ones for all risk scores (log-rank test P |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Plný text